Within the past 2 years, interest in investigator-initiated clinical trials has increased greatly. The additional proof of practice and clinical application data that these types of trials provide have allowed for the transition of many newly approved therapies to standard practice.
While research offices are doing their best to support these endeavors, the additional administrative responsibilities involved are often unfamiliar, as they are normally taken on by industry sponsors and outside governmental agencies, including the new “final rule” requirements.
Join Velos and PFS Clinical for an informative, no-cost webinar on investigator-initiated trials and the "final rule" requirements on Thursday, September 14 at 12:00 PM CST. Besides getting tips and models for meeting requirements, learn how technology can help you develop protocols, observe compliance, and simplify submissions to clinicaltrials.gov.
Register here: anymeeting.com/PIID=ED52DE86844C38